1Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea
2Department of Pediatrics, College of Korean Medicine, Kyung Hee University, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea
3Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
4Department of Pediatrics, College of Korean Medicine, Kyung Hee University, Kyung Hee University Medical Center, Seoul, Republic of Korea
©2023 Jaseng Medical Foundation
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Author Contributions
Conceptualization: JYL. Data curation: SGP. Formal analysis: SGP. Funding acquisition: SHL. Investigation: SGP. Methodology: GTC. Project administration: SHL. Resources: GTC. Software: SGP. Supervision: SHL. Validation: SGP. Visualization: SHL. Writing original draft: SGP. Writing - review and editing: GTC, JYL, and SHL.
Conflicts of Interest
The authors declare that they have no competing interests.
Funding
Conduction of the study was supported by the Bodyfriend, Inc. (Seoul, Republic of Korea).
Ethical Statement
The study was performed in accordance with the principles of the Declaration of Helsinki, and the Ethical Guidelines for Clinical Research, and the Institutional Review Board of Kyung Hee University Korean Medicine Hospital (no.: KOMCIRB 2019-03-002). The participants were given a complete explanation of the study, and written informed consent was obtained from the children and their parent, carer, or guardian.
Characteristics | Total | Male | Female |
---|---|---|---|
General characteristics | |||
|
|||
Sex (M/F) | 31 | 17 | 14 |
Maternal height (cm) | 159.63 ± 5.14 | 160.91 ± 4.25 | 158.07 ± 5.84 |
Paternal height (cm) | 173.55 ± 4.83 | 174.59 ± 5.04 | 172.29 ± 4.41 |
Mid parental height (cm) | 167.23 ± 8.71 | 174.25 ± 4.01 | 158.68 ± 3.45 |
|
|||
Baseline | |||
|
|||
Chronological age (y) | 11.44 ± 0.33 | 11.40 ± 0.31 | 11.48 ± 0.35 |
Bone age (y) | 11.91 ± 0.98 | 11.75 ± 1.13 | 12.11 ± 0.74 |
Sexual maturity rating (I/II/III/IV/V) | 11/11/5/4/0 | 11/5/1/0/0 | 0/6/4/4/0 |
Nutrition intake (good/bad) § | 31/0 | 17/0 | 14/0 |
Time spent exercising (0–0.5/0.5–1/1–2/ > 2 h/d) | 10/11/10/0 | 3/7/7/0 | 7/4/3/0 |
Height percentile | 59.06 ± 20.51 | 63.89 ± 20.47 | 53.20 ± 19.70 |
Height (cm) | 149.67 ± 2.56 | 149.97 ± 2.90 | 149.31 ± 2.13 |
Height SDS (cm) † | 0.27 ± 0.58 | 0.40 ± 0.58 | 0.10 ± 0.55 |
Height SDS for bone age (cm) † | −0.15 ± 0.98 | 0.07 ± 1.15 | −0.42 ± 0.67 |
Expected height estimatied by bone age (cm) ‡ | 174.16 ± 8.01 | 178.53 ± 4.17 | 163.56 ± 3.81 |
Sitting height (cm) | 80.15 ± 1.83 | 80.22 ± 1.92 | 80.05 ± 1.78 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.53 ± 0.01 | 0.54 ± 0.01 |
Weight (kg) | 45.57 ± 7.02 | 47.43 ± 6.61 | 43.32 ± 7.08 |
BMI (kg/m2) | 20.34 ± 3.10 | 21.11 ± 3.03 | 19.42 ± 3.03 |
GH level (ng/ML) | 1.70 ± 3.14 | 1.65 ± 3.77 | 1.79 ± 2.31 |
IGF-1 level (ng/ML) | 327.81 ± 125.89 | 252.06 ± 100.13 | 419.79 ± 87.28 |
IGFBP-3 level (ng/ML) | 6,105.81 ± 1125.26 | 5,667.06 ± 1,080.84 | 6,638.57 ± 962.7 |
|
|||
End point | |||
|
|||
Chronological age (y) | 12.41 ± 0.98 | 11.90 ± 0.31 | 11.98 ± 0.35 |
Bone age (y) | 12.47 ± 0.77 | 12.38 ± 0.88 | 12.57 ± 0.63 |
Sexual maturity rating (I/II/III/IV/V) | 7/10/10/4/0 | 7/8/2/0/0 | 0/2/8/4/0 |
Nutrition intake (good/bad)§ | 29/2 | 15/2 | 14/0 |
Time spent exercising (0–0.5/0.5–1/1–2/ > 2 h/d) | 15/10/5/1 | 7/6/3/1 | 8/4/2/0 |
Height percentile | 61.45 ± 21.56 | 65.12 ± 21.59 | 56.99 ± 21.45 |
Height (cm) | 153.31 ± 3.10 | 153.84 ± 3.50 | 152.66 ± 2.51 |
Height SDS† (cm) | 0.34 ± 0.62 | 0.45 ± 0.64 | 0.20 ± 0.60 |
Height SDS† for bone age (cm) | −0.11 ± 0.84 | −0.01 ± 0.91 | −0.24 ± 0.76 |
Expected height estimated by bone age (cm) ‡ | 174.87 ± 7.66 | 178.96 ± 4.12 | 163.94 ± 4.59 |
Sitting height (cm) | 82.26 ± 2.00 | 82.41 ± 2.31 | 82.08 ± 1.62 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.54 ± 0.01 | 0.54 ± 0.01 |
Weight (kg) | 49.86 ± 7.58 | 51.95 ± 7.26 | 47.34 ± 7.43 |
BMI (kg/m2) | 21.04 ± 3.18 | 21.98 ± 3.27 | 19.90 ± 2.77 |
* Continuous valuables are expressed as mean ± SD.
† SDS = (measured value - mean value of the reference population)/standard deviation of the reference population.
‡ Seven patients (S-KH-01, 11, 21, 23, 25, 33, 37) had menarche before the age of 12 and were excluded from the estimation of predicted height.
§ Nutrition intake was determined as good when bread, cereals and potatoes; fruit and vegetables; milk, cheese and dairy; meat, fish, and alternatives; fats, oils, and confectionery were all consumed according to nutrition survey.
BMI = body mass index; GH = growth hormone; IGF-1 = insulin-like growth factor-1; IGFBP-3 = insulin-like growth factor binding protein-3; SDS = standard deviation score.
Pre-post comparision (n = 31) | Pre-intervention | Post-intervention | Mean difference (95% CI) | Analysis | p |
---|---|---|---|---|---|
Height percentile | 59.06 ± 20.51 | 61.45 ± 21.56 | 2.39 ± 5.91 (0.22–4.55) | Paired t-test | 0.032* |
Height (cm) | 149.67 ± 2.56 | 153.31 ± 3.10 | 3.64 ± 1.28 (3.17–4.11) | Paired t-test | < 0.001*** |
Height SDS (cm) | 0.27 ± 0.58 | 0.34 ± 0.62 | 0.07 ± 0.18 (0.01–0.14) | Paired t-test | 0.036* |
Height SDS for bone age (cm) | −0.15 ± 0.98 | −0.11 ± 0.84 | 0.04 ± 0.43 (−0.12–0.20) | Paired t-test | 0.603 |
Predicted adult height estimatied by bone age (cm)* | 174.16 ± 8.01 | 174.87 ± 7.66 | 0.71 ± 1.78 (−0.04–1.46) | Paired t-test | 0.063 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.54 ± 0.01 | 0.00 ± 0.01 (0.00–0.00) | Paired t-test | 0.479 |
BMI (kg/m2) | 20.34 ± 3.10 | 21.04 ± 3.18 | 0.70 ± 0.79 (0.41–0.99) | Paired t-test | < 0.001*** |
|
|||||
Comparison with presumed data | Presumed Visit 5 | Visit 5 | Mean difference (95% CI) | Analysis† | p |
|
|||||
Height (cm) | 152.87 ± 2.72 | 153.31 ± 3.10 | 0.44 ± 1.22 (−0.01–0.89) | Paired t-test | 0.053 |
Weight (kg) | 48.23 ± 7.45 | 49.86 ± 7.58 | 1.63 ± 3.07 (0.51–2.76) | Paired t-test | 0.006** |
Bone age (y) | 12.41 ± 0.98 | 12.47 ± 0.77 | 0.05 ± 0.45 (−0.11–0.22) | Paired t-test | 0.526 |
|
|||||
Visit 2 - Presumed Visit 5 | Visit 2 - Visit 5 | Mean difference (95% CI) | Analysis† | p | |
|
|||||
Growth rate (mm/d) | 0.18 ± 0.02 | 0.20 ± 0.07 | 0.02 ± 0.07 (0.00–0.05) | Paired t-test | 0.054 |
Pre-post comparision | Baseline height SDS < 0 (n = 11) | Baseline height SDS ≥ 0 (n = 20) | ||||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
Pre-intervention | Post-intervention | Analysis | p | Pre-intervention | Post-intervention | Analysis | p | |
Height percentile | 34.81 ± 6.84 | 36.42 ± 11.51 | Wilcoxon signed-rank test‡ | 0.898 | 72.40 ± 10.58 | 75.22 ± 10.10 | Paired t-test | 0.014* |
Height (cm) | 147.48 ± 1.79 | 150.61 ± 2.03 | Paired t-test | < 0.001*** | 150.88 ± 2.09 | 154.80 ± 2.55 | Paired t-test | < 0.001*** |
Height SDS (cm) | −0.40 ± 0.18 | −0.36 ± 0.31 | Wilcoxon signed-rank test‡ | 0.898 | 0.63 ± 0.34 | 0.72 ± 0.36 | Paired t-test | 0.025* |
Height SDS for bone age (cm) | −0.51 ± 0.71 | −0.50 ± 0.59 | Paired t-test | 0.921 | 0.04 ± 1.07 | 0.10 ± 0.89 | Paired t-test | 0.546 |
Predicted adult height estimatied by bone age (cm) † | 167.67 ± 7.32 | 168.27 ± 6.64 | Paired t-test | 0.391 | 178.06 ± 5.61 | 178.83 ± 5.14 | Paired t-test | 0.102 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.53 ± 0.01 | Paired t-test | 0.856 | 0.54 ± 0.01 | 0.54 ± 0.01 | Paired t-test | 0.294 |
BMI (kg/m2) | 19.17 ± 2.12 | 19.72 ± 2.09 | Paired t-test | 0.039* | 20.99 ± 3.40 | 21.77 ± 3.49 | Paired t-test | < 0.001*** |
|
||||||||
Comparison with presumed data | Presumed Visit 5 | Visit 5 | Analysis | p | Presumed Visit 5 | Visit 5 | Analysis | p |
|
||||||||
Height (cm) | 150.42 ± 1.54 | 150.61 ± 2.03 | Paired t-test | 0.635 | 154.22 ± 2.25 | 154.80 ± 2.55 | Paired t-test | 0.042* |
Weight (kg) | 44.02 ± 5.15 | 44.76 ± 5.07 | Paired t-test | 0.145 | 50.55 ± 7.59 | 52.67 ± 7.34 | Paired t-test | 0.016* |
Bone age (y) | 12.43 ± 0.88 | 12.48 ± 0.59 | Paired t-test | 0.765 | 12.40 ± 1.05 | 12.46 ± 0.87 | Wilcoxon signed-rank test‡ | 0.694 |
|
||||||||
Visit 2 - Presumed Visit 5 | Visit 2 - Visit 5 | Analysis | p | Visit 2 - Presumed Visit 5 | Visit 2 - Visit 5 | Analysis | p | |
|
||||||||
Growth rate (mm/d) | 0.16 ± 0.03 | 0.17 ± 0.07 | Wilcoxon signed-rank test‡ | 0.922 | 0.18 ± 0.02 | 0.22 ± 0.07 | Wilcoxon signed-rank test‡ | 0.070 |
* p < 0.05.
** p < 0.01.
*** p < 0.001.
† Seven patients (S-KH-01, 11, 21, 23, 25, 33, 37) had menarche before the age of 12 and were excluded from the estimation of predicted height.
‡ A paired t-test was used for the analyses of changes within groups. If normality assumption was not met, a Wilcoxon signed rank test on difference was used.
BMI = body mass index; SDS = standard deviation score.
Characteristics | Total | Male | Female |
---|---|---|---|
General characteristics | |||
| |||
Sex (M/F) | 31 | 17 | 14 |
Maternal height (cm) | 159.63 ± 5.14 | 160.91 ± 4.25 | 158.07 ± 5.84 |
Paternal height (cm) | 173.55 ± 4.83 | 174.59 ± 5.04 | 172.29 ± 4.41 |
Mid parental height (cm) | 167.23 ± 8.71 | 174.25 ± 4.01 | 158.68 ± 3.45 |
| |||
Baseline | |||
| |||
Chronological age (y) | 11.44 ± 0.33 | 11.40 ± 0.31 | 11.48 ± 0.35 |
Bone age (y) | 11.91 ± 0.98 | 11.75 ± 1.13 | 12.11 ± 0.74 |
Sexual maturity rating (I/II/III/IV/V) | 11/11/5/4/0 | 11/5/1/0/0 | 0/6/4/4/0 |
Nutrition intake (good/bad) |
31/0 | 17/0 | 14/0 |
Time spent exercising (0–0.5/0.5–1/1–2/ > 2 h/d) | 10/11/10/0 | 3/7/7/0 | 7/4/3/0 |
Height percentile | 59.06 ± 20.51 | 63.89 ± 20.47 | 53.20 ± 19.70 |
Height (cm) | 149.67 ± 2.56 | 149.97 ± 2.90 | 149.31 ± 2.13 |
Height SDS (cm) |
0.27 ± 0.58 | 0.40 ± 0.58 | 0.10 ± 0.55 |
Height SDS for bone age (cm) |
−0.15 ± 0.98 | 0.07 ± 1.15 | −0.42 ± 0.67 |
Expected height estimatied by bone age (cm) |
174.16 ± 8.01 | 178.53 ± 4.17 | 163.56 ± 3.81 |
Sitting height (cm) | 80.15 ± 1.83 | 80.22 ± 1.92 | 80.05 ± 1.78 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.53 ± 0.01 | 0.54 ± 0.01 |
Weight (kg) | 45.57 ± 7.02 | 47.43 ± 6.61 | 43.32 ± 7.08 |
BMI (kg/m2) | 20.34 ± 3.10 | 21.11 ± 3.03 | 19.42 ± 3.03 |
GH level (ng/ML) | 1.70 ± 3.14 | 1.65 ± 3.77 | 1.79 ± 2.31 |
IGF-1 level (ng/ML) | 327.81 ± 125.89 | 252.06 ± 100.13 | 419.79 ± 87.28 |
IGFBP-3 level (ng/ML) | 6,105.81 ± 1125.26 | 5,667.06 ± 1,080.84 | 6,638.57 ± 962.7 |
| |||
End point | |||
| |||
Chronological age (y) | 12.41 ± 0.98 | 11.90 ± 0.31 | 11.98 ± 0.35 |
Bone age (y) | 12.47 ± 0.77 | 12.38 ± 0.88 | 12.57 ± 0.63 |
Sexual maturity rating (I/II/III/IV/V) | 7/10/10/4/0 | 7/8/2/0/0 | 0/2/8/4/0 |
Nutrition intake (good/bad) |
29/2 | 15/2 | 14/0 |
Time spent exercising (0–0.5/0.5–1/1–2/ > 2 h/d) | 15/10/5/1 | 7/6/3/1 | 8/4/2/0 |
Height percentile | 61.45 ± 21.56 | 65.12 ± 21.59 | 56.99 ± 21.45 |
Height (cm) | 153.31 ± 3.10 | 153.84 ± 3.50 | 152.66 ± 2.51 |
Height SDS |
0.34 ± 0.62 | 0.45 ± 0.64 | 0.20 ± 0.60 |
Height SDS |
−0.11 ± 0.84 | −0.01 ± 0.91 | −0.24 ± 0.76 |
Expected height estimated by bone age (cm) |
174.87 ± 7.66 | 178.96 ± 4.12 | 163.94 ± 4.59 |
Sitting height (cm) | 82.26 ± 2.00 | 82.41 ± 2.31 | 82.08 ± 1.62 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.54 ± 0.01 | 0.54 ± 0.01 |
Weight (kg) | 49.86 ± 7.58 | 51.95 ± 7.26 | 47.34 ± 7.43 |
BMI (kg/m2) | 21.04 ± 3.18 | 21.98 ± 3.27 | 19.90 ± 2.77 |
Pre-post comparision (n = 31) | Pre-intervention | Post-intervention | Mean difference (95% CI) | Analysis | p |
---|---|---|---|---|---|
Height percentile | 59.06 ± 20.51 | 61.45 ± 21.56 | 2.39 ± 5.91 (0.22–4.55) | Paired t-test | 0.032 |
Height (cm) | 149.67 ± 2.56 | 153.31 ± 3.10 | 3.64 ± 1.28 (3.17–4.11) | Paired t-test | < 0.001 |
Height SDS (cm) | 0.27 ± 0.58 | 0.34 ± 0.62 | 0.07 ± 0.18 (0.01–0.14) | Paired t-test | 0.036 |
Height SDS for bone age (cm) | −0.15 ± 0.98 | −0.11 ± 0.84 | 0.04 ± 0.43 (−0.12–0.20) | Paired t-test | 0.603 |
Predicted adult height estimatied by bone age (cm) |
174.16 ± 8.01 | 174.87 ± 7.66 | 0.71 ± 1.78 (−0.04–1.46) | Paired t-test | 0.063 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.54 ± 0.01 | 0.00 ± 0.01 (0.00–0.00) | Paired t-test | 0.479 |
BMI (kg/m2) | 20.34 ± 3.10 | 21.04 ± 3.18 | 0.70 ± 0.79 (0.41–0.99) | Paired t-test | < 0.001 |
| |||||
Comparison with presumed data | Presumed Visit 5 | Visit 5 | Mean difference (95% CI) | Analysis† | p |
| |||||
Height (cm) | 152.87 ± 2.72 | 153.31 ± 3.10 | 0.44 ± 1.22 (−0.01–0.89) | Paired t-test | 0.053 |
Weight (kg) | 48.23 ± 7.45 | 49.86 ± 7.58 | 1.63 ± 3.07 (0.51–2.76) | Paired t-test | 0.006 |
Bone age (y) | 12.41 ± 0.98 | 12.47 ± 0.77 | 0.05 ± 0.45 (−0.11–0.22) | Paired t-test | 0.526 |
| |||||
Visit 2 - Presumed Visit 5 | Visit 2 - Visit 5 | Mean difference (95% CI) | Analysis† | p | |
| |||||
Growth rate (mm/d) | 0.18 ± 0.02 | 0.20 ± 0.07 | 0.02 ± 0.07 (0.00–0.05) | Paired t-test | 0.054 |
Pre-post comparision | Baseline height SDS < 0 (n = 11) | Baseline height SDS ≥ 0 (n = 20) | ||||||
---|---|---|---|---|---|---|---|---|
|
| |||||||
Pre-intervention | Post-intervention | Analysis | p | Pre-intervention | Post-intervention | Analysis | p | |
Height percentile | 34.81 ± 6.84 | 36.42 ± 11.51 | Wilcoxon signed-rank test |
0.898 | 72.40 ± 10.58 | 75.22 ± 10.10 | Paired t-test | 0.014 |
Height (cm) | 147.48 ± 1.79 | 150.61 ± 2.03 | Paired t-test | < 0.001 |
150.88 ± 2.09 | 154.80 ± 2.55 | Paired t-test | < 0.001 |
Height SDS (cm) | −0.40 ± 0.18 | −0.36 ± 0.31 | Wilcoxon signed-rank test |
0.898 | 0.63 ± 0.34 | 0.72 ± 0.36 | Paired t-test | 0.025 |
Height SDS for bone age (cm) | −0.51 ± 0.71 | −0.50 ± 0.59 | Paired t-test | 0.921 | 0.04 ± 1.07 | 0.10 ± 0.89 | Paired t-test | 0.546 |
Predicted adult height estimatied by bone age (cm) |
167.67 ± 7.32 | 168.27 ± 6.64 | Paired t-test | 0.391 | 178.06 ± 5.61 | 178.83 ± 5.14 | Paired t-test | 0.102 |
Sitting height/height ratio | 0.54 ± 0.01 | 0.53 ± 0.01 | Paired t-test | 0.856 | 0.54 ± 0.01 | 0.54 ± 0.01 | Paired t-test | 0.294 |
BMI (kg/m2) | 19.17 ± 2.12 | 19.72 ± 2.09 | Paired t-test | 0.039 |
20.99 ± 3.40 | 21.77 ± 3.49 | Paired t-test | < 0.001 |
| ||||||||
Comparison with presumed data | Presumed Visit 5 | Visit 5 | Analysis | p | Presumed Visit 5 | Visit 5 | Analysis | p |
| ||||||||
Height (cm) | 150.42 ± 1.54 | 150.61 ± 2.03 | Paired t-test | 0.635 | 154.22 ± 2.25 | 154.80 ± 2.55 | Paired t-test | 0.042 |
Weight (kg) | 44.02 ± 5.15 | 44.76 ± 5.07 | Paired t-test | 0.145 | 50.55 ± 7.59 | 52.67 ± 7.34 | Paired t-test | 0.016 |
Bone age (y) | 12.43 ± 0.88 | 12.48 ± 0.59 | Paired t-test | 0.765 | 12.40 ± 1.05 | 12.46 ± 0.87 | Wilcoxon signed-rank test |
0.694 |
| ||||||||
Visit 2 - Presumed Visit 5 | Visit 2 - Visit 5 | Analysis | p | Visit 2 - Presumed Visit 5 | Visit 2 - Visit 5 | Analysis | p | |
| ||||||||
Growth rate (mm/d) | 0.16 ± 0.03 | 0.17 ± 0.07 | Wilcoxon signed-rank test |
0.922 | 0.18 ± 0.02 | 0.22 ± 0.07 | Wilcoxon signed-rank test |
0.070 |
Continuous valuables are expressed as mean ± SD. SDS = (measured value - mean value of the reference population)/standard deviation of the reference population. Seven patients (S-KH-01, 11, 21, 23, 25, 33, 37) had menarche before the age of 12 and were excluded from the estimation of predicted height. Nutrition intake was determined as good when bread, cereals and potatoes; fruit and vegetables; milk, cheese and dairy; meat, fish, and alternatives; fats, oils, and confectionery were all consumed according to nutrition survey. BMI = body mass index; GH = growth hormone; IGF-1 = insulin-like growth factor-1; IGFBP-3 = insulin-like growth factor binding protein-3; SDS = standard deviation score.
Seven patients (S-KH-01, 11, 21, 23, 25, 33, 37) had menarche before the age of 12 and were excluded from the estimation of predicted height. BMI = body mass index; SDS = standard deviation score.
Seven patients (S-KH-01, 11, 21, 23, 25, 33, 37) had menarche before the age of 12 and were excluded from the estimation of predicted height. A paired BMI = body mass index; SDS = standard deviation score.